Myriam Curet McAdams - 27 Jan 2026 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet
Issuer symbol
ISRG
Transactions as of
27 Jan 2026
Net transactions value
-$72,302
Form type
4
Filing time
28 Jan 2026, 16:34:15 UTC
Previous filing
02 Jan 2026
Next filing
30 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curet Myriam EVP & Chief Medical Officer 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet 28 Jan 2026 0001632901

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $24,086 +105 $229.39 105 27 Jan 2026 Direct F1
transaction ISRG Common Stock Sale $55,924 -105 -100% $532.61 0 27 Jan 2026 Direct F1
transaction ISRG Common Stock Options Exercise $26,112 +125 $208.90 125 27 Jan 2026 Direct F1
transaction ISRG Common Stock Sale $66,576 -125 -100% $532.61 0 27 Jan 2026 Direct F1
holding ISRG Common Stock 353 27 Jan 2026 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -125 -33% $0.000000 251 27 Jan 2026 Common Stock 125 $208.90 Direct F1, F2
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -105 -7.2% $0.000000 1,362 27 Jan 2026 Common Stock 105 $229.39 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
F2 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F3 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.